Fennec Pharmaceuticals Inc.
FENC
Revenue
7.26M
▼-18.12M▼-71.38%
3 Months ChangeAssets
63.16M
▼-6.03M▼-8.72%
3 Months ChangeLiabilities
64.52M
▼-1.66M▼-2.51%
3 Months ChangeFree Cash Flow
-443.00k
▼-33.00k▼-8.05%
3 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001104659-24-112405
2024-08-13
Form 10-Q
ID: 0001558370-24-012074
2024-08-07
Form 8-K
ID: 0001104659-24-086369
2024-07-02
Form 8-K
ID: 0001104659-24-076936
2024-06-25
Form 8-K
ID: 0001104659-24-074748
2024-05-14
Form 10-Q
ID: 0001558370-24-008162
2024-05-09
Form 8-K
ID: 0001104659-24-058960
2024-03-25
Form 8-K
ID: 0001104659-24-038444
2024-03-21
Form 8-K
ID: 0001104659-24-037255
2024-02-29
Form 8-K
ID: 0001104659-24-029355